Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $36.6000 (-1.11%) ($35.3600 - $37.4700) on Mon. Jun. 4, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.48% (three month average) | RSI | 53 | Latest Price | $36.6000(-1.11%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EDIT advances 1.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.74% in a week (0% probabilities). VXX(-13%) VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.74% (StdDev 3.48%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
5 Day Moving Average | $37.1(-1.35%) | 10 Day Moving Average | $36.3(0.83%) | 20 Day Moving Average | $35.8(2.23%) | To recent high | -17% | To recent low | 16.6% | Market Cap | $2.273b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |